Allspring Global Investments
RVMD icon

Allspring Global Investments’s Revolution Medicines RVMD Stock Holding History

Allspring Global Investments’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,992
Closed -$1.24M – 1781
2025
Q1 		$1.24M Sell
36,992
-22,751
-38% -$923K ﹤0.01% 1201
2024
Q4 		$2.63M Buy
59,743
+21,154
+55% +$1.07M ﹤0.01% 1089
2024
Q3 		$1.75M Buy
38,589
+35,399
+1,110% +$1.54M ﹤0.01% 1196
2024
Q2 		$124K Sell
3,190
-28
-0.9% -$1.05K ﹤0.01% 1806
2024
Q1 		$104K Buy
+3,218
New +$95.4K ﹤0.01% 1839
2023
Q4 		– Sell
-3,250
Closed -$90K – 2658
2023
Q3 		$90K Sell
3,250
-1,443
-31% -$42.8K ﹤0.01% 2039
2023
Q2 		$126K Buy
4,693
+1,561
+50% +$38.3K ﹤0.01% 1978
2023
Q1 		$67.8K Buy
3,132
+1,366
+77% +$33.6K ﹤0.01% 2186
2022
Q4 		$42.1K Sell
1,766
-39
-2% -$829 ﹤0.01% 2383
2022
Q3 		$35K Sell
1,805
-267
-13% -$5.87K ﹤0.01% 2471
2022
Q2 		$40K Sell
2,072
-12,310
-86% -$240K ﹤0.01% 2317
2022
Q1 		$366K Buy
14,382
+716
+5% +$15.6K ﹤0.01% 2363
2021
Q4 		$343K Buy
+13,666
New +$385K ﹤0.01% 2450

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Allspring Global Investments's RVMD Position: Q2 2025 in Review

Allspring Global Investments sold out of Revolution Medicines (RVMD) in Q2 2025, closing a stake of 36,992 shares — an estimated $1.24M sold.

Allspring Global Investments first reported a position in RVMD in Q4 2021 and held it in 13 quarters. The position peaked at $2.63M in Q4 2024. 307 funds tracked by Wall St. Rank hold RVMD as of Q2 2025.

  • Allspring Global Investments reported no remaining Revolution Medicines position as of Q2 2025 after selling out during the quarter.
  • Allspring Global Investments sold 36,992 Revolution Medicines shares in Q2 2025, an estimated $1.24M.
  • Allspring Global Investments first reported a position in Revolution Medicines in Q4 2021 and held it in 13 quarters.
  • Allspring Global Investments's Revolution Medicines position peaked at $2.63M in Q4 2024.
  • 307 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2025.

Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.